Abortion Takes Center Stage in States as Federal Action Stalls

Access to abortion pills and other reproductive services will have another contentious year in 2026 across state legislatures as the Trump administration is expected to slow-walk further action.

Criminalization of providers, reclassifying abortion drugs as controlled substances, and in-person dispensing requirements are among the issues percolating in legislatures across the US. At the federal level, the Trump administration has yet to deliver on a long-awaited mifepristone safety study that could upend availability of the abortion pill, paving the way for legislatures to take a greater role in reining in reproductive services within their borders.

“The anti’s will stop at nothing,” ...